SYVC — Synovics Pharmaceuticals Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Synovics Pharmaceuticals, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2004 October 31st | R2005 October 31st | R2006 October 31st | 2007 October 31st | 2008 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.099 | 0.008 | 10.5 | 23.5 | 26 |
| Cost of Revenue | |||||
| Gross Profit | 0.081 | -0.037 | 2.36 | 6.63 | 8.97 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.885 | 1.92 | 14.1 | 37.7 | 25.8 |
| Operating Profit | -0.786 | -1.91 | -3.62 | -14.3 | 0.183 |
| Total Net Non Operating Interest Income / Expense | |||||
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.12 | -2.69 | -7.53 | -20.9 | -4 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.12 | -2.69 | -7.53 | -20.9 | -4 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -1.12 | -2.91 | -8.57 | -20.9 | -4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -1.12 | -2.91 | -8.57 | -20.9 | -4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.143 | -0.135 | -0.289 | -0.873 | -0.282 |
| Dividends per Share |